Dimensional Fund Advisors LP Cellectar Biosciences, Inc. Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$11.8 - $18.2 $250,927 - $387,023
-21,265 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$15.2 - $25.0 $165,391 - $272,025
-10,881 Reduced 33.85%
21,265 $34,000
Q4 2020

Feb 25, 2021
BUY
$11.2 - $27.7 $360,035 - $890,444
32,146 New
32,146 $67,000

About Cellectar Biosciences, Inc.

CLRB Quotes by TradingView
  • Ticker CLRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 6,114,290
  • Market Cap $9.17M
  • Description
  • Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...
More about CLRB
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email